| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Recce Pharmaceuticals Ltd (AU: RCE)
RCE Technical Analysis
5
| As on 24th Dec 2024 RCE STOCK Price closed @ 0.46 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.53 & Strong Sell for SHORT-TERM with Stoploss of 0.63 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RCESTOCK Price
| Open | 0.45 | Change | Price | % |
| High | 0.46 | 1 Day | 0.00 | 0.00 |
| Low | 0.45 | 1 Week | -0.04 | -8.00 |
| Close | 0.46 | 1 Month | -0.01 | -2.13 |
| Volume | 12693 | 1 Year | -0.24 | -34.29 |
| 52 Week High 0.74 | 52 Week Low 0.42 | ||||
AU Australia Most Active Stocks
| SBM | 0.20 | -33.33% |
| RGL | 0.00 | % |
| SYA | 0.03 | 0.00% |
| HWK | 0.09 | % |
| BRN | 0.32 | 6.67% |
| TMG | 0.04 | 0.00% |
| CPH | 0.01 | 0.00% |
| CHM | 0.01 | 0.00% |
| Z1P | 0.46 | -11.54% |
| AAU | 0.00 | % |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| RCE Daily Charts |
RCE Intraday Charts |
Whats New @ Bazaartrend |
RCE Free Analysis |
|
|
RCE Important Levels Intraday
| RESISTANCE | 0.48 |
| RESISTANCE | 0.47 |
| RESISTANCE | 0.47 |
| RESISTANCE | 0.47 |
| SUPPORT | 0.45 |
| SUPPORT | 0.45 |
| SUPPORT | 0.45 |
| SUPPORT | 0.44 |
RCE Forecast December 2024
| 4th UP Forecast | 1.04 |
| 3rd UP Forecast | 0.85 |
| 2nd UP Forecast | 0.74 |
| 1st UP Forecast | 0.62 |
| 1st DOWN Forecast | 0.3 |
| 2nd DOWN Forecast | 0.18 |
| 3rd DOWN Forecast | 0.07 |
| 4th DOWN Forecast | -0.12 |
RCE Weekly Forecast
| 4th UP Forecast | 0.65 |
| 3rd UP Forecast | 0.59 |
| 2nd UP Forecast | 0.55 |
| 1st UP Forecast | 0.51 |
| 1st DOWN Forecast | 0.41 |
| 2nd DOWN Forecast | 0.37 |
| 3rd DOWN Forecast | 0.33 |
| 4th DOWN Forecast | 0.27 |
RCE Forecast2024
| 4th UP Forecast | 1.19 |
| 3rd UP Forecast | 0.96 |
| 2nd UP Forecast | 0.81 |
| 1st UP Forecast | 0.67 |
| 1st DOWN Forecast | 0.25 |
| 2nd DOWN Forecast | 0.11 |
| 3rd DOWN Forecast | -0.04 |
| 4th DOWN Forecast | -0.27 |
Recce Pharmaceuticals Ltd ( AU Australia Symbol : RCE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RCE Business Profile
Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of synthetic anti?infectives in Australia, the United States, and the United Kingdom. The company's lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. It also develops RECCE 529, a synthetic anti-infective for viral infections; and RECCE 435, a synthetic polymer anti-infective. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia. Address: Aurora Place, Sydney, NSW, Australia, 2000
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service